Courtney Dugan | executive |
Michael Rossi | executive |
Sue Smith | executive |
Vignesh Rajah | executive |
Bo Kruse | executive |
Alec Stranahan | analyst |
David Nierengarten | analyst |
Lukas Shumway | analyst |
Good morning, and welcome to the Y-mAbs Therapeutics Earnings Conference Call for the Fourth Quarter and Full Year of 2023. [Operator Instructions] As a reminder, today's conference will be recorded. I'll now turn the call over to Y-mAbs Head of Investor Relations, Courtney Dugan.
Thank you, operator, and good morning, everyone. Welcome to the Y-mAbs Fourth Quarter and Full Year 2023 Financial Results Conference Call. We issued a press release with our results yesterday after market close.